{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:55:12Z","timestamp":1790481312206,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1038\/s41401-022-01039-6","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T07:03:10Z","timestamp":1673334190000},"page":"1122-1134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Pharmacological characterization of the small molecule 03A10 as an inhibitor of \u03b1-synuclein aggregation for Parkinson\u2019s disease treatment"],"prefix":"10.1038","volume":"44","author":[{"given":"Qing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-xian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-liang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-yin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"1039_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397:2284\u2013303.","journal-title":"Lancet"},{"key":"1039_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18:435\u201350.","journal-title":"Nat Rev Neurosci"},{"key":"1039_CR3","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.2174\/1570159X15666171129100944","volume":"16","author":"U Ganguly","year":"2018","unstructured":"Ganguly U, Chakrabarti SS, Kaur U, Mukherjee A, Chakrabarti S. Alpha-synuclein, Proteotoxicity and Parkinson\u2019s disease: search for neuroprotective therapy. Curr Neuropharmacol. 2018;16:1086\u201397.","journal-title":"Curr Neuropharmacol"},{"key":"1039_CR4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","volume":"134","author":"N Bengoa-Vergniory","year":"2017","unstructured":"Bengoa-Vergniory N, Roberts RF, Wade-Martins R, Alegre-Abarrategui J. Alpha-synuclein oligomers: a new hope. Acta Neuropathol. 2017;134:819\u201338.","journal-title":"Acta Neuropathol"},{"key":"1039_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 2004;318:121\u201334.","journal-title":"Cell Tissue Res"},{"key":"1039_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","volume":"11","author":"L Klingelhoefer","year":"2015","unstructured":"Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease\u2013the gut-brain axis and environmental factors. Nat Rev Neurol. 2015;11:625\u201336.","journal-title":"Nat Rev Neurol"},{"key":"1039_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/mds.28483","volume":"36","author":"AJ Baumgartner","year":"2021","unstructured":"Baumgartner AJ, Press DZ, Simon DK. The relationship between olfactory dysfunction and constipation in early Parkinson\u2019s disease. Mov Disord. 2021;36:781\u20132.","journal-title":"Mov Disord"},{"key":"1039_CR8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103:627\u201341.","journal-title":"Neuron"},{"key":"1039_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-018-0257-5","volume":"13","author":"N Uemura","year":"2018","unstructured":"Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R. Inoculation of alpha-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener. 2018;13:21.","journal-title":"Mol Neurodegener"},{"key":"1039_CR10","doi-asserted-by":"crossref","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM, Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T Human \u03b1-Synuclein. Neuron 2002;34:521\u201333.","DOI":"10.1016\/S0896-6273(02)00682-7"},{"key":"1039_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.expneurol.2016.09.004","volume":"285","author":"Q Wu","year":"2016","unstructured":"Wu Q, Yang X, Zhang Y, Zhang L, Feng L. Chronic mild stress accelerates the progression of Parkinson\u2019s disease in A53T alpha-synuclein transgenic mice. Exp Neurol. 2016;285:61\u201371.","journal-title":"Exp Neurol"},{"key":"1039_CR12","doi-asserted-by":"crossref","unstructured":"Hu H, Wang Q, Du J, Liu Z, Ding Y, Xue H, et al. Aha1 exhibits distinctive dynamics behavior and chaperone-like activity. Molecules 2021;26:1943.","DOI":"10.3390\/molecules26071943"},{"key":"1039_CR13","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley LA, Luk KC, Lee VM. Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc. 2014;9:2135\u201346.","journal-title":"Nat Protoc"},{"key":"1039_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, et al. Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron. 2011;72:57\u201371.","journal-title":"Neuron"},{"key":"1039_CR15","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O'Brien P, Stieber A, Branch JR, Brunden KR, Trojanowski JQ, Lee VM. Exogenous \u03b1-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. PNAS. 2009;106:20051\u20136.","journal-title":"PNAS"},{"key":"1039_CR16","doi-asserted-by":"crossref","unstructured":"Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A, NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 1995;6:277\u201393.","DOI":"10.1007\/BF00197809"},{"key":"1039_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nmeth979","volume":"3","author":"I Remy","year":"2006","unstructured":"Remy I, Michnick SW. A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat Methods. 2006;3:977\u20139.","journal-title":"Nat Methods"},{"key":"1039_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nrm1929","volume":"7","author":"TK Kerppola","year":"2006","unstructured":"Kerppola TK. Visualization of molecular interactions by fluorescence complementation. Nat Rev Mol Cell Biol. 2006;7:449\u201356.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1039_CR19","doi-asserted-by":"publisher","first-page":"104538","DOI":"10.1016\/j.phrs.2019.104538","volume":"150","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Wu Q, Zhang L, Wang Q, Yang Z, Liu J, et al. Caffeic acid reduces A53T alpha-synuclein by activating JNK\/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease. Pharm Res. 2019;150:104538.","journal-title":"Pharm Res"},{"key":"1039_CR20","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S1097-2765(02)00496-3","volume":"9","author":"CD Hu","year":"2002","unstructured":"Hu CD, Chinenov Y, Kerppola TK. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell. 2002;9:789\u201398.","journal-title":"Mol Cell"},{"key":"1039_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2020.01.026","volume":"112","author":"BB McAllister","year":"2020","unstructured":"McAllister BB, Lacoursiere SG, Sutherland RJ, Mohajerani MH. Intracerebral seeding of amyloid-beta and tau pathology in mice: Factors underlying prion-like spreading and comparisons with alpha-synuclein. Neurosci Biobehav Rev. 2020;112:1\u201327.","journal-title":"Neurosci Biobehav Rev"},{"key":"1039_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"MD Tuttle","year":"2016","unstructured":"Tuttle MD, Comellas G, Nieuwkoop AJ, Covell DJ, Berthold DA, Kloepper KD, et al. Solid-state NMR structure of a pathogenic fibril of full-length human alpha-synuclein. Nat Struct Mol Biol. 2016;23:409\u201315.","journal-title":"Nat Struct Mol Biol"},{"key":"1039_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"1039_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","volume":"8","author":"RL Doty","year":"2012","unstructured":"Doty RL. Olfactory dysfunction in Parkinson\u2019s disease. Nat Rev Neurol. 2012;8:329\u201339.","journal-title":"Nat Rev Neurol"},{"key":"1039_CR25","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, et al. Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord. 2015;30:1351\u201360.","journal-title":"Mov Disord"},{"key":"1039_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02007-1","volume":"21","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Hu J, Feng JW, Hu XT, Wang T, Gong WX, et al. Influenza infection elicits an expansion of gut population of endogenous Bifidobacterium animalis which protects mice against infection. Genome Biol. 2020;21:99.","journal-title":"Genome Biol"},{"key":"1039_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","volume":"16","author":"CH Hawkes","year":"2010","unstructured":"Hawkes CH, Del Tredici K, Braak H. A timeline for Parkinson\u2019s disease. Parkinsonism Relat Disord. 2010;16:79\u201384.","journal-title":"Parkinsonism Relat Disord"},{"key":"1039_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","volume":"23","author":"C Challis","year":"2020","unstructured":"Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, et al. Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci. 2020;23:327\u201336.","journal-title":"Nat Neurosci"},{"key":"1039_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ. alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature. 2011;477:107\u201310.","journal-title":"Nature"},{"key":"1039_CR30","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1126\/science.aan6160","volume":"358","author":"G Fusco","year":"2017","unstructured":"Fusco G, Chen SW, Williamson PTF, Cascella R, Perni M, Jarvis JA, et al. Structural basis of membrane disruption and cellular toxicity by alpha-synuclein oligomers. Science. 2017;358:1440\u20133.","journal-title":"Science"},{"key":"1039_CR31","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","volume":"28","author":"Y Li","year":"2018","unstructured":"Li Y, Zhao C, Luo F, Liu Z, Gui X, Luo Z, et al. Amyloid fibril structure of alpha-synuclein determined by cryo-electron microscopy. Cell Res. 2018;28:897\u2013903.","journal-title":"Cell Res"},{"key":"1039_CR32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.neuroscience.2016.10.042","volume":"339","author":"TT Zhao","year":"2016","unstructured":"Zhao TT, Shin KS, Kim KS, Park HJ, Kim HJ, Lee KE, et al. Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson\u2019s disease treated with l-DOPA. Neuroscience. 2016;339:644\u201354.","journal-title":"Neuroscience"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-01039-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-01039-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-01039-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T09:03:10Z","timestamp":1684746190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-01039-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1039"],"URL":"https:\/\/doi.org\/10.1038\/s41401-022-01039-6","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"18 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}